Rein Therapeutics Ownership | Who Owns Rein Therapeutics?


OverviewFinancialsChart

Rein Therapeutics Ownership Summary


Rein Therapeutics is owned by 303761.73% institutional investors, 0.15% insiders. Hexagon capital partners is the largest institutional shareholder, holding 0% of RNTX shares.

RNTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockRein Therapeutics303761.73%0.15%-303661.88%
SectorHealthcare Stocks 486.50%11.08%-397.59%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Hexagon capital partners---
Two sigma securities---
Game plan financial advisors---
Jpmorgan chase---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Hexagon capital partners---
Two sigma securities---
Game plan financial advisors---
Jpmorgan chase---

Top Buyers

HolderShares% AssetsChange
Game plan financial advisors---25.00
Jpmorgan chase---32.00
Hexagon capital partners---213.00
Two sigma securities---16.27K

Top Sellers

HolderShares% AssetsChange
Two sigma securities---16.27K
Hexagon capital partners---213.00
Jpmorgan chase---32.00
Game plan financial advisors---25.00

Sold Out

HolderChange
Game plan financial advisors-25.00
Jpmorgan chase-32.00
Hexagon capital partners-213.00
Two sigma securities-16.27K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202535-5.41%6,657,20910.63%303,7610.04%14-62.16%5-
Mar 31, 202536-5,995,080-27,636-36---

Insider Transactions Trends


DateBuySell
2025 Q3--

RNTX Ownership FAQ


Who owns the most shares of Rein Therapeutics?

Rein Therapeutics’s largest shareholders are Hexagon capital partners (0 shares, 0%), Two sigma securities (0 shares, 0%), and Game plan financial advisors (0 shares, 0%). Together, they hold 0% of Rein Therapeutics’s total shares outstanding.

Does Blackrock own Rein Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Rein Therapeutics.

Who is Rein Therapeutics’s biggest shareholder by percentage of total assets invested?

Hexagon capital partners is Rein Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Rein Therapeutics shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools